<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Endoscopic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance has been advocated for patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, only a small minority of patients dies from <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>It has been calculated that endoscopic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance will only add to the quality of life of individuals in whom the incidence of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is greater than 1/200 patient-years </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVE: To determine the proportion of a consecutive cohort of patients, in whom <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> was diagnosed over a 5-year period, likely to benefit from endoscopic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> patients who had died during the observation period or were over 75 years old and those with diseases likely to impair survival were excluded </plain></SENT>
<SENT sid="5" pm="."><plain>Next, <z:hpo ids='HP_0000001'>all</z:hpo> patients in whom the risk of developing <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> fell below 1/200 patient-years were excluded (including <z:hpo ids='HP_0000001'>all</z:hpo> women, <z:hpo ids='HP_0000001'>all</z:hpo> men under the age of 60 and <z:hpo ids='HP_0000001'>all</z:hpo> men with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> of &lt; 3 cm in length) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of any degree and/or presence of an <z:mpath ids='MPATH_579'>ulcer</z:mpath> or stricture in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> were reinstated </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Of 335 adult patients diagnosed with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> but without <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> or high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 75 had died from unrelated causes, 47 had other diseases limiting survival and 59 were over 75 years old </plain></SENT>
<SENT sid="8" pm="."><plain>After exclusion of <z:hpo ids='HP_0000001'>all</z:hpo> women, <z:hpo ids='HP_0000001'>all</z:hpo> men with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> of &lt; 3 cm in length and <z:hpo ids='HP_0000001'>all</z:hpo> men under 60 years old, 15 patients were left </plain></SENT>
<SENT sid="9" pm="."><plain>However, 32 were reinstated because of risk factors and another five because of insufficient data, resulting in 52 of the original 335 patients (15.5%) being eligible for endoscopic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: This study suggests that less than 20% of patients identified with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> at routine endoscopy would benefit from endoscopic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance </plain></SENT>
<SENT sid="11" pm="."><plain>Prospective surveillance programmes should be limited to patients with an increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk and a good health profile </plain></SENT>
</text></document>